"When we started out, the expectation was that we would consider ourselves successful if we stopped the progression of the disease," Margolin said. "Lo and behold, people actually got better -- and not (just) occasionally. ... That was the real icing on the cake."
Is it me, or are others slightly sceptical of these stories? In the last 18 months, we've seen such stories in relation to Aimspro. Neurovax, Tovaxin, Rituxan and now this drug. Always examples of fantastic improvements - does anyone know someone who has had MS for 30 years and still rides horses?
Sorry to put a damper on this story, but fund raising from the drugs companies seems to be the primary motive. This is a cruel disease, but more cruel is the companies who feed these stories to the press, yet the drugs haven't reached the latter trial stages.